Rockefeller Financial Services Inc. grew its holdings in Thermo Fisher Scientific Inc (NYSE:TMO) by 85.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 18,389 shares of the medical research company’s stock after purchasing an additional 8,477 shares during the quarter. Rockefeller Financial Services Inc.’s holdings in Thermo Fisher Scientific were worth $3,479,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also made changes to their positions in TMO. Cibc World Markets Corp lifted its stake in shares of Thermo Fisher Scientific by 6.9% in the 1st quarter. Cibc World Markets Corp now owns 210,776 shares of the medical research company’s stock valued at $32,375,000 after purchasing an additional 13,660 shares during the period. Patton Albertson Miller Group LLC lifted its stake in shares of Thermo Fisher Scientific by 5.7% in the 1st quarter. Patton Albertson Miller Group LLC now owns 8,319 shares of the medical research company’s stock valued at $1,432,000 after purchasing an additional 449 shares during the period. Mastrapasqua Asset Management Inc. lifted its stake in shares of Thermo Fisher Scientific by 2.8% in the 1st quarter. Mastrapasqua Asset Management Inc. now owns 39,056 shares of the medical research company’s stock valued at $5,999,000 after purchasing an additional 1,057 shares during the period. Dynamic Technology Lab Private Ltd acquired a new position in shares of Thermo Fisher Scientific in the 1st quarter valued at about $1,167,000. Finally, Tredje AP fonden lifted its stake in shares of Thermo Fisher Scientific by 11.2% in the 1st quarter. Tredje AP fonden now owns 43,773 shares of the medical research company’s stock valued at $6,730,000 after purchasing an additional 4,406 shares during the period. 83.78% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION WARNING: This article was originally reported by Watch List News and is the sole property of of Watch List News. If you are reading this article on another site, it was illegally stolen and reposted in violation of US and international copyright law. The original version of this article can be read at https://www.watchlistnews.com/thermo-fisher-scientific-inc-tmo-stake-lifted-by-rockefeller-financial-services-inc/1704207.html.

In other news, VP Peter E. Hornstra sold 3,894 shares of the company’s stock in a transaction that occurred on Tuesday, September 5th. The stock was sold at an average price of $185.18, for a total value of $721,090.92. Following the completion of the transaction, the vice president now directly owns 19,751 shares of the company’s stock, valued at $3,657,490.18. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director C Martin Harris sold 360 shares of the company’s stock in a transaction that occurred on Wednesday, August 30th. The shares were sold at an average price of $180.97, for a total value of $65,149.20. Following the completion of the transaction, the director now directly owns 5,312 shares of the company’s stock, valued at $961,312.64. The disclosure for this sale can be found here. Insiders have sold a total of 22,738 shares of company stock valued at $4,021,512 over the last three months. Corporate insiders own 0.49% of the company’s stock.

Shares of Thermo Fisher Scientific Inc (NYSE:TMO) opened at $189.08 on Wednesday. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.81 and a current ratio of 1.26. The company has a market capitalization of $75,471.34, a P/E ratio of 20.68, a price-to-earnings-growth ratio of 1.72 and a beta of 1.08. Thermo Fisher Scientific Inc has a twelve month low of $139.07 and a twelve month high of $201.20.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 EPS for the quarter, topping analysts’ consensus estimates of $2.24 by $0.07. The firm had revenue of $5.12 billion during the quarter, compared to analyst estimates of $5.03 billion. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The company’s revenue for the quarter was up 13.9% on a year-over-year basis. During the same period in the previous year, the company posted $2.03 EPS. sell-side analysts predict that Thermo Fisher Scientific Inc will post 9.36 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Friday, December 15th will be issued a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 0.32%. The ex-dividend date is Thursday, December 14th. Thermo Fisher Scientific’s dividend payout ratio is currently 10.19%.

TMO has been the topic of a number of recent analyst reports. Cleveland Research raised Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a research note on Thursday, July 20th. Bank of America Corporation reissued a “buy” rating and issued a $210.00 price objective (up from $200.00) on shares of Thermo Fisher Scientific in a research note on Friday, July 21st. Zacks Investment Research downgraded Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. BidaskClub downgraded Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Finally, Argus reaffirmed a “buy” rating on shares of Thermo Fisher Scientific in a research note on Tuesday, August 22nd. They noted that the move was a valuation call. One equities research analyst has rated the stock with a hold rating and sixteen have given a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $205.71.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.